The Journal of Bone and Joint Surgery 83:572 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.
A Randomized Trial of Controlled-Release Oxycodone During Inpatient Rehabilitation Following Unilateral Total Knee Arthroplasty
Andrea Cheville, MD,
Alice Chen, MD,
Gerry Oster, PhD,
Lisa McGarry, MPH and
Elizabeth Narcessian, MD
Investigation performed at Kessler Institute for Rehabilitation,
East Orange and West Orange, New Jersey
No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. No funds were received in support of this study. Andrea Cheville, MD
Department of Rehabilitation Medicine, University of Pennsylvania
Health System, 3400 Spruce Street, 5 West Gates, Philadelphia, PA
19104.
E-mail address: cheville{at}mail.med.upenn.edu
Alice Chen, MD
Beth Israel Medical Center, 170 East End Avenue, New York, NY 10128
Gerry Oster, PhD
Lisa McGarry, MPH
Policy Analysis, Incorporated, 4 Davis Court, Brookline, MA 02445
Elizabeth Narcessian, MD
Deceased
Background:
Reliance on "as-needed" analgesia following
total knee arthroplasty may lead to inadequate control of pain and
delayed recovery of function. Preemptive use of controlled-release
opioids may improve pain control, accelerate recovery, and reduce
the need for inpatient rehabilitative services. This study was designed
to determine whether controlled-release opioids enhance post-arthroplasty
pain control and facilitate functional recovery during rehabilitation.
Methods:
Fifty-nine patients admitted for inpatient rehabilitation following
unilateral total knee arthroplasty were randomized to receive OxyContin
(controlled-release oxycodone) (twenty-nine patients) or a placebo
(thirty patients) every twelve hours. Both groups could receive
on-request, immediate-release oxycodone (5 mg every four hours).
The dose of study medication was increased on the basis of the frequency
of requests for immediate-release oxycodone. Measures of interest
included pain ratings as determined with a visual-analog scale,
changes in the range of motion of the knee and quadriceps strength,
and improvements in selected Functional Independence Measure scores
during the first eight physical therapy sessions. The duration of
the hospital stay for rehabilitation also was compared between the
two groups.
Results:
Baseline demographic, clinical, and functional characteristics
were similar between the OxyContin and placebo groups. Compared
with the placebo group, the patients who received OxyContin reported
significantly less pain as well as significantly greater range of
motion of the knee (passive motion, p = 0.036; active motion,
p < 0.001) and quadriceps strength (p = 0.001)
by the eighth physical therapy session. The patients who received OxyContin
also were discharged from the rehabilitation hospital at an average
of 2.3 days earlier than the patients in the placebo group (p = 0.013).
Conclusions:
Preemptive use of controlled-release oxycodone during rehabilitation
following total knee arthroplasty leads to improved pain control,
more rapid functional recovery, and a reduced need for inpatient
rehabilitative services.

CiteULike Connotea Del.icio.us Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Levine and R. K. Burdick
Controlled-Release Oxycodone
J. Am. Acad. Ortho. Surg.,
January 1, 2005;
13(1):
1 - 4.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Botte, K. A. Ezzet, L. L. Pacelli, M. J. Guzman, R. S. Meyer, M. J. Meunier, D. D. D'Lima, and C. W. Colwell
What's New in Orthopaedic Rehabilitation
J. Bone Joint Surg. Am.,
December 9, 2002;
84(12):
2312 - 2320.
[Full Text]
[PDF]
|
 |
|
|